Expand this Topic clickable element to expand a topic
Skip to content
Optica Publishing Group
  • Chinese Optics Letters
  • Vol. 7,
  • Issue 10,
  • pp. 894-897
  • (2009)

Interaction between antitumor drug and silver nanoparticles: combined fluorscence and surface enhanced Raman scattering study

Not Accessible

Your library or personal account may give you access

Abstract

Optical methods and MTT method are used to characterize the antiproliferation effect of antitumor drug 9-aminoacridine (9AA) with and without silver nanoparticles. Intracellular surface enhanced Raman scattering (SERS) spectra and fluorescent spectra of 9AA indicate the form of 9AA adsorbed on the surface of silver nanoparticles. Although both silver nanoparticles and antitumor drug can inhibit the growth of Hela cells, silver nanoparticles can slow down the antiproliferation effect on Hela cells at low concentration of antitumor drugs. Our experimental results suggest that silver nanoparticles may serve as slow-release drug carriers, which is important in antitumor drug delivery.

© 2009 Chinese Optics Letters

PDF Article
More Like This
Photoreduced silver nanoparticles grown on femtosecond laser ablated, D-shaped fiber probe for surface-enhanced Raman scattering

Zhen Yin, Youfu Geng, Qingli Xie, Xueming Hong, Xiaoling Tan, Yuzhi Chen, Lele Wang, Wenjia Wang, and Xuejin Li
Appl. Opt. 55(20) 5408-5412 (2016)

Leukemia cells detection based on electroporation assisted surface-enhanced Raman scattering

Yun Yu, Juqiang Lin, Duo Lin, Shangyuan Feng, Weiwei Chen, Zufang Huang, Hao Huang, and Rong Chen
Biomed. Opt. Express 8(9) 4108-4121 (2017)

Cited By

You do not have subscription access to this journal. Cited by links are available to subscribers only. You may subscribe either as an Optica member, or as an authorized user of your institution.

Contact your librarian or system administrator
or
Login to access Optica Member Subscription

Select as filters


Select Topics Cancel
© Copyright 2024 | Optica Publishing Group. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies.